The common gamma radiotherapy process lacks accuracy when it comes to analyze prostate, lung, head and neck, liver, esophagus and brain cancers. This project will show the benefits of using TOF-PET in Proton Therapy to increase the performance of Proton Therapy equipment, allowing a more accurate radiation.
The proton therapy used in cancer therapy produces short-lived positron-emitting radioisotopes, such as 15O, 13N and 11C, that can be detected by Positron Emission Tomography (PET) imaging. The strength and time dependence of this image allows assessing the efficacy of the proton treatment in-vivo.
Due to geometrical constraints, the in-beam PET scanning in proton radiation therapy is very difficult to achieve since it is impossible to fully surround the patient with a ring of detectors, as is normally required in PET scanning. However, the use of PET, together with very good TOF, allows obtaining better PET images, with partial angular coverage around the patient.
Once the PET scanner is built, the researchers will use phantom head models to ascertain and verify isotope production maps by a proton beam at MD Anderson. Computer simulations will predict the distribution of the positron annihilation events that should be observed. Any mismatch with the observation will provide feedback to adjust the beam.
The project is going to demonstrate the diagnostic value of the state-of-the-art PET scanner featuring excellent position resolution and Time-of-Flight (TOF) to register positron-emitting radionuclides during and immediately after the proton irradiation.
- A PET system prototype to be used in a Proton Therapy equipment, suitable for radiation monitoring of the head and neck cancers;
- Scientific papers for publication.
|Start Date – End Date:||January 1, 2020 – December 31, 2022|
|Scientific Area:||Medical Physics|
Proton Therapy, TOF PET, Positron Emission Tomography, SiPM readout, TOFPET ASIC
|Lead Beneficiary (PT):||PETsys Electronics – Medical Pet Detectors, S.A.|
|LIP, Laboratório de Instrumentação e Física Experimental de Particulas – Associação para a Investigação e Desenvolvimento
Instituto Superior Técnico
Universidade de Coimbra
|PIs at UT Austin:||Karol Lang (College of Natural Sciences, Department of Physics, UT Austin)
Narayan Sahoo (Department of Radiation Physics, Division of Radiation Oncology, UT MD Anderson Cancer Center)
|Total Eligible Investment (PT):||1 253 179,56 EUR|
|Total Eligible Investment (US):||849 987,00 USD|
|Funding Sources Distribution:|
Papers and Communications
- Cudalbeanu, M., Peitinho, D., Silva, F., Marques, R., Pinheiro, T., Ferreira, A. C., Marques, F., Paulo, A., Soeiro, C. F., Sousa, S. A., Leitão, J. H., Tăbăcaru, A., Avramescu, S. M., Dinica, R. M., & Campello, M. P. C. (2021). Sono-Biosynthesis and Characterization of AuNPs from Danube Delta Nymphaea alba Root Extracts and Their Biological Properties. Nanomaterials MDPI.
- Pinto, C. I. G., Bucar, S., Alves, V., Fonseca, A., Abrunhosa, A. J., da Silva, C. L., Guerreiro, J. F., & Mendes, F. (2020). Copper-64 Chloride Exhibits Therapeutic Potential in Three-Dimensional Cellular Models of Prostate Cancer. Frontiers in Molecular Biosciences.
- Silva, F., Paulo, A., Pallier, A., Même, S., Tóth, É., Gano, L., Marques, F., Geraldes, C. F. G. C., Castro, M. M. C. A., Cardoso, A. M., Jurado, A. S., López-Larrubia, P., Lacerda, S., & Cabral Campello, M. P. (2020). Dual Imaging Gold Nanoplatforms for Targeted Radiotheranostics. Materials MDPI.
- Francisco Silva, António Paulo, Agnès Pallier, Sandra Même, Éva Tóth, Lurdes Gano, Fernanda Marques, Carlos FGC Geraldes, M Margarida CA Castro, Ana M Cardoso, Amália S Jurado, Pilar López-Larrubia, Sara Lacerda, Maria Paula Cabral Campello. (2020). Dual Imaging Gold Nanoplatforms for Targeted Radiotheranostics. Prime Archives in Material Science: 2nd Edition.
2020 Annual Conference
2021 Annual Conference